CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Substance Abuse, Oral

Abuse, overuse, or misuse of a substance by ingestion.

Drugs by status

Phase 4 trials (12)

  • oxytocin
  • alprazolam
  • oxycodone
  • gabapentin
  • naltrexone
  • cabotegravir
  • testosterone
  • diazepam
  • atomoxetine
  • quetiapine
  • pregabalin
  • chlorhexidine

Phase 3 trials (2)

  • paliperidone
  • aripiprazole

Phase 2 trials (8)

  • acetylcysteine
  • ketamine
  • methylphenidate
  • tenofovir
  • tramadol
  • hydromorphone
  • morphine
  • tirzepatide

Phase 1 trials (21)

  • almorexant
  • lasmiditan
  • epoetin
  • tozadenant
  • Carfentanil
  • cebranopadol
  • suvorexant
  • rapastinel
  • sodium oxybate
  • dronabinol
  • nicotine
  • tetrahydrocannabinol
  • triazolam
  • zolpidem
  • psilocybin
  • sodium chloride
  • pentobarbital
  • clomifene
  • amphetamine
  • seltorexant
  • cvl-936

Other trials (7)

  • fluticasone
  • ethanol
  • lithium
  • furosemide
  • bupropion
  • amisulpride
  • albuterol

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.